Table 4.
Aneuploidy Mean ± SD by detection of individual urinary organophosphate metabolite levels (n=159).
| Metabolitea | %XX18 | %YY18 | %XY18 | %Total Disomy |
|---|---|---|---|---|
| DMP | ||||
| Q1 | 0.49±0.48 | 0.39±0.37 | 1.27±0.98 | 2.15±1.53 |
| Q2 | 0.45±0.59 | 0.31±0.20 | 1.00±0.61 | 1.76±1.09 |
| Q3 | 0.36±0.29 | 0.39±0.26 | 0.92±0.74 | 1.67±1.06 |
| Q4 | 0.38±0.32 | 0.31±0.17 | 1.13±0.68 | 1.81±0.95 |
| DMTP | ||||
| Q1 | 0.36±0.29 | 0.37±0.21 | 1.15±0.68 | 1.88±0.89 |
| Q2 | 0.52±0.59 | 0.40±0.43 | 1.21±1.18 | 2.12±1.86 |
| Q3 | 0.42±0.40 | 0.37±0.27 | 1.01±0.60 | 1.81±1.01 |
| Q4 | 0.41±0.41 | 0.31±0.18 | 1.13±0.69 | 1.85±1.01 |
| DMDTP | ||||
| Q1 | 0.46±0.49 | 0.38±0.36 | 1.20±0.97 | 2.04±1.52 |
| Q2 | 0.50±0.49 | 0.30±0.19 | 1.21±0.75 | 2.01±1.19 |
| Q3 | 0.41±0.44 | 0.38±0.28 | 1.00±0.80 | 1.79±1.14 |
| Q4 | 0.33±0.23 | 0.36±0.20 | 0.98±0.53 | 1.67±0.78 |
| DEP | ||||
| Q1 | 0.37±0.26 | 0.35±0.25 | 1.11±0.69 | 1.83±0.97 |
| Q2 | 0.58±0.64 | 0.47±0.45 | 1.35±1.26 | 2.40±1.98 |
| Q3 | 0.36±0.43 | 0.32±0.23 | 0.86±0.56 | 1.53±0.93 |
| Q4 | 0.48±0.44 | 0.30±0.15 | 1.18±0.65 | 1.95±1.00 |
| DETP | ||||
| Q1 | 0.40±0.36 | 0.33±0.20 | 1.24±0.81 | 1.96±1.08 |
| Q2 | 0.44±0.48 | 0.36±0.29 | 0.93±0.52 | 1.74±0.98 |
| Q3 | 0.46±0.44 | 0.44±0.41 | 1.34±1.17 | 2.25±1.88 |
| Q4 | 0.44±0.51 | 0.32±0.23 | 0.97±0.62 | 1.73±0.97 |
| DEDTP | ||||
| G1 | 0.44±0.46 | 0.37±0.30 | 1.15±0.86 | 1.95±1.31 |
| G2 | 0.43±0.33 | 0.28±0.16 | 0.93±0.51 | 1.64±0.85 |
| ΣDAPs | ||||
| T1 | 0.50±0.53 | 0.37±0.38 | 1.27±1.07 | 2.14±1.65 |
| T2 | 0.46±0.48 | 0.40±0.29 | 1.08±0.74 | 1.94±1.17 |
| T3 | 0.35±0.28 | 0.31±0.18 | 1.02±0.61 | 1.68±0.86 |
DMP Exposure Quartiles: Q1=X≤LOD (n=68), Q2=0.60<X≤7.95 ng/mL (n=30), Q3=7.95<X≤13.39 ng/mL (n=30), Q4=X>13.39 ng/mL (n=31). DMTP Exposure Quartiles: Q1=X≤LOD (n=30), Q2=0.20<X≤2.21 ng/mL (n=43), Q3=2.21<X≤6.47 ng/mL (n=42), Q4=X>6.47 ng/mL (n=44). DMDTP Exposure Quartiles: Q1=X≤LOD (n=69), Q2=0.10<X≤0.73 ng/mL (n=30), Q3=0.73<X≤1.86 ng/mL (n=30), Q4=X>1.86 ng/mL (n=30). DEP Exposure Quartiles: Q1=X≤LOD (n=58), Q2=0.20<X≤1.46 ng/mL (n=34), Q3=1.46<X≤3.96 ng/mL (n=33), Q4=X>3.96 ng/mL (n=34). DETP Exposure Quartiles: Q1=X≤LOD (n=45), Q2=0.10<X≤0.62 ng/mL (n=39), Q3=0.62<X≤1.51 ng/mL (n=37), Q4=X>1.51 ng/mL (n=38). DEDTP Exposure Group: G1=X≤LOD (n=143); G2=X>0.10 ng/mL (n=16). ΣDAPs Exposure Tertiles: T1=2.76≤×≤35.00 nmol/mL (n=53), T2=35.00<X≤155.00 nmol/mL (n=52), T3=X>155.01 nmol/mL (n=54).